TOP2 Antikörper (C-Term)
-
- Target Alle TOP2 Antikörper anzeigen
- TOP2 (DNA Topoisomerase II (TOP2))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser TOP2 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA
- Kreuzreaktivität
- Human
- Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
- Produktmerkmale
- Topoisomerase II (DNA) alpha
- Aufreinigung
- Purified by immunoaffinity chromatography.
- Immunogen
- 18aa peptide from ~C-terminus of human Topoisomerase II alpha. Sequence is 100% conserved in alternatively spliced isoforms 2-4 of human TOP2A.
- Klon
- 7C52
- Isotyp
- IgG
- Top Product
- Discover our top product TOP2 Primärantikörper
-
anti-DNA Topoisomerase II (TOP2) (AA 923-1148) antibody
TOP2 Reaktivität: Human WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-DNA Topoisomerase II (TOP2) (AA 1079-1328) antibodyTOP2 Reaktivität: Ratte WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-DNA Topoisomerase II (TOP2) (AA 749-987) antibodyTOP2 Reaktivität: Maus WB, IHC, ICC Wirt: Kaninchen Polyclonal unconjugated
anti-DNA Topoisomerase II (TOP2) (C-Term), (N-Term) antibodyTOP2 Reaktivität: Arabidopsis thaliana, Vicia faba WB, IL Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Optimal working conditions should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
- Supplied as a lyophilized powder from PBS, 0.05 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C
-
- Target
- TOP2 (DNA Topoisomerase II (TOP2))
- Abstract
- TOP2 Produkte
- Synonyme
- Topoii antikoerper, ptr11 antikoerper, DDBDRAFT_0191045 antikoerper, DDBDRAFT_0231510 antikoerper, DDB_0191045 antikoerper, DDB_0231510 antikoerper, CG10223 antikoerper, CHRAC antikoerper, Dmel\\CG10223 antikoerper, TOP2 antikoerper, TOPO II antikoerper, TOPOII antikoerper, TopII antikoerper, Topo II antikoerper, TopoII antikoerper, dCHRAC antikoerper, dTopoII antikoerper, top2 antikoerper, topo II antikoerper, topoII antikoerper, topoisomerase II antikoerper, DNA topoisomerase II antikoerper, DNA topoisomerase 2 antikoerper, DNA topoisomerase ii antikoerper, type IIA topoisomerase; DNA gyrase topoisomerase IV B subunit antikoerper, Topoisomerase 2 antikoerper, TOP2 antikoerper, A583L antikoerper, top2 antikoerper, CNA03600 antikoerper, Tb09.160.4090 antikoerper, Tb11.01.3390 antikoerper, LMJF_28_2280 antikoerper, Top2 antikoerper
- Pathways
- Mitotic G1-G1/S Phases
-
